Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

PRMT2 and RORγ expression are associated with breast cancer survival outcomes.

Oh TG, Bailey P, Dray E, Smith AG, Goode J, Eriksson N, Funder JW, Fuller PJ, Simpson ER, Tilley WD, Leedman PJ, Clarke CL, Grimmond S, Dowhan DH, Muscat GE.

Mol Endocrinol. 2014 Jul;28(7):1166-85. doi: 10.1210/me.2013-1403.

PMID:
24911119
2.

Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.

Zhong J, Cao RX, Zu XY, Hong T, Yang J, Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH, Wen GB.

FEBS J. 2012 Jan;279(2):316-35. doi: 10.1111/j.1742-4658.2011.08426.x.

3.

Nuclear loss of protein arginine N-methyltransferase 2 in breast carcinoma is associated with tumor grade and overexpression of cyclin D1 protein.

Zhong J, Cao RX, Liu JH, Liu YB, Wang J, Liu LP, Chen YJ, Yang J, Zhang QH, Wu Y, Ding WJ, Hong T, Xiao XH, Zu XY, Wen GB.

Oncogene. 2014 Nov 27;33(48):5546-58. doi: 10.1038/onc.2013.500.

PMID:
24292672
4.

Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.

Zhong J, Cao RX, Hong T, Yang J, Zu XY, Xiao XH, Liu JH, Wen GB.

Gene. 2011 Nov 1;487(1):1-9. doi: 10.1016/j.gene.2011.06.022.

PMID:
21820040
5.

Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion.

Dai M, Al-Odaini AA, Fils-Aimé N, Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S, Lebrun JJ.

Breast Cancer Res. 2013 Jun 20;15(3):R49. doi: 10.1186/bcr3441.

7.

Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.

Zuo X, Qin Y, Zhang X, Ning Q, Shao S, Luo M, Yuan N, Huang S, Zhao X.

Oncol Rep. 2014 May;31(5):2358-64. doi: 10.3892/or.2014.3107.

PMID:
24676336
8.

Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.

Dowhan DH, Harrison MJ, Eriksson NA, Bailey P, Pearen MA, Fuller PJ, Funder JW, Simpson ER, Leedman PJ, Tilley WD, Brown MA, Clarke CL, Muscat GE.

Endocr Relat Cancer. 2012 Jul 22;19(4):509-26. doi: 10.1530/ERC-12-0100.

9.

The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.

Gao Y, Zhao Y, Zhang J, Lu Y, Liu X, Geng P, Huang B, Zhang Y, Lu J.

Sci Rep. 2016 Jan 27;6:19874. doi: 10.1038/srep19874.

10.

CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

Al-Dhaheri M, Wu J, Skliris GP, Li J, Higashimato K, Wang Y, White KP, Lambert P, Zhu Y, Murphy L, Xu W.

Cancer Res. 2011 Mar 15;71(6):2118-28. doi: 10.1158/0008-5472.CAN-10-2426.

11.

IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.

Zuo S, Liu C, Wang J, Wang F, Xu W, Cui S, Yuan L, Chen X, Fan W, Cui M, Song G.

J Cancer Res Clin Oncol. 2012 Jun;138(6):1045-55. doi: 10.1007/s00432-012-1153-y.

PMID:
22392074
12.

PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.

Meyer R, Wolf SS, Obendorf M.

J Steroid Biochem Mol Biol. 2007 Oct;107(1-2):1-14.

PMID:
17587566
13.

MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells.

Zhao Y, Li Y, Lou G, Zhao L, Xu Z, Zhang Y, He F.

PLoS One. 2012;7(6):e39102. doi: 10.1371/journal.pone.0039102.

14.

Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells.

Baldwin RM, Morettin A, Paris G, Goulet I, Côté J.

Cell Cycle. 2012 Dec 15;11(24):4597-612. doi: 10.4161/cc.22871.

15.

Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.

Strong AL, Ohlstein JF, Biagas BA, Rhodes LV, Pei DT, Tucker HA, Llamas C, Bowles AC, Dutreil MF, Zhang S, Gimble JM, Burow ME, Bunnell BA.

Breast Cancer Res. 2015 Aug 19;17:112. doi: 10.1186/s13058-015-0622-z.

16.

Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).

Wei M, Liu B, Gu Q, Su L, Yu Y, Zhu Z.

Cell Oncol (Dordr). 2013 Feb;36(1):79-93. doi: 10.1007/s13402-012-0115-3.

PMID:
23184467
17.

Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.

Mohapatra P, Satapathy SR, Das D, Siddharth S, Choudhuri T, Kundu CN.

Toxicol Appl Pharmacol. 2014 Mar 15;275(3):221-31. doi: 10.1016/j.taap.2014.01.011.

PMID:
24467951
18.

Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks.

Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, Reliene R.

Mol Carcinog. 2014 Jun;53(6):458-70. doi: 10.1002/mc.21995.

PMID:
23359482
19.

Cyclin D1, Id1 and EMT in breast cancer.

Tobin NP, Sims AH, Lundgren KL, Lehn S, Landberg G.

BMC Cancer. 2011 Sep 28;11:417. doi: 10.1186/1471-2407-11-417.

20.

Gene methylation in gastric cancer.

Qu Y, Dang S, Hou P.

Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Review.

Items per page

Supplemental Content

Support Center